TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call Transcript March 24, 2026
TELA Bio, Inc. misses on earnings expectations. Reported EPS is $-0.16 EPS, expectations were $-0.155.
Operator: Good afternoon, ladies and gentlemen, and welcome to the TELA Bio, Inc. Fourth Quarter and Full Year 2025 Earnings Conference Call. At this time, participants are in listen-only mode. A question-and-answer session will follow the prepared remarks. As a reminder, this conference call is being recorded. I...
